Publications by authors named "Bernardo Rossini"

Claim this Profile
A
AI-derived five-gene signature predicts risk in multiple myeloma under bortezomib-based therapy.
Grazia Gargano, Susanna Anita Pappagallo, Angela Maria Quinto, Bernardo Rossini, Doriana Gramegna

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single versus double autologous stem cell transplantation and lenalidomide maintenance versus no maintenance therapy in newly-diagnosed patients with multiple myeloma: a real-life, vintage snapshot after twenty-three years from the Rete Ematologica Pugliese.
Nicola Di Renzo, Emanuela Resta, Michelina Dargenio, Nicola Sgherza, Francesco Tarantini, Bernardo Rossini

Ann Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Sgherza et al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. 2025, , 595.
Nicola Sgherza, Olga Battisti, Paola Curci, Concetta Conticello, Salvatore Palmieri, Bernardo Rossini

Pharmaceuticals (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Myeloma in Italy: An Epidemiological Model by Treatment Line and Refractoriness Status.
Roberto Mina, Silvia Mangiacavalli, Bernardo Rossini, Gianni Ghetti, Simona Pellizzaro

Clin Lymphoma Myeloma Leuk· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study.
Nicola Sgherza, Olga Battisti, Paola Curci, Concetta Conticello, Salvatore Palmieri, Bernardo Rossini

Pharmaceuticals (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is whole body low dose CT still necessary in the era of F-FDG PET/CT for the assessment of bone disease in multiple myeloma patients?
Nicola Maggialetti, Cristina Ferrari, Anna Giulia Nappi, Angela Quinto, Bernardo Rossini

Hell J Nucl Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials.
Enrica Antonia Martino, Salvatore Palmieri, Monica Galli, Daniele Derudas, Roberto Mina, Bernardo Rossini

Hematol Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences.
Bernardo Rossini, Nicola Cecchi, Felice Clemente, Maria Rosaria De Paolis, Stefan Hohaus

Drugs Context· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials.
Massimo Gentile, Ernesto Vigna, Salvatore Palmieri, Monica Galli, Daniele Derudas, Bernardo Rossini

Haematologica· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence on the use of daratumumab, bortezomib and dexamethasone (DVd) in lenalidomide-refractory myeloma patients: subgroup analysis of the multicenter retrospective experience by "rete ematologica pugliese".
Giuseppe Mele, Nicola Di Renzo, Nicola Cascavilla, Angelo Michele Carella, Attilio Guarini, Bernardo Rossini

Leuk Lymphoma· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology.
Gian Maria Zaccaria, Vito Colella, Simona Colucci, Felice Clemente, Fabio Pavone, Bernardo Rossini

Sci Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary, Bilateral and Diffuse Renal Non-Hodgkin's Lymphoma in a Young Woman Suffering from Turner Syndrome.
Bernardo Rossini, Tetiana Skrypets, Carla Minoia, Angela Maria Quinto, Gian Maria Zaccaria

J Pers Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi.
Annalisa Chiappella, Alessandra Tucci, Alessia Castellino, Vincenzo Pavone, Ileana Baldi, Bernardo Rossini

Haematologica· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.
Annunziata De Luisi, Laura Binetti, Roberto Ria, Simona Ruggieri, Simona Berardi, Bernardo Rossini

Angiogenesis· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma.
Michele Moschetta, Antonio Basile, Arianna Ferrucci, Maria Antonia Frassanito, Luigia Rao, Bernardo Rossini

Clin Cancer Res· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
Antonio Basile, Michele Moschetta, Paolo Ditonno, Roberto Ria, Ilaria Marech, Bernardo Rossini

J Pathol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plerixafor added to chemotherapy plus G-CSF is safe and allows adequate PBSC collection in predicted poor mobilizer patients with multiple myeloma or lymphoma.
Immacolata Attolico, Vincenzo Pavone, Angelo Ostuni, Bernardo Rossini, Maurizio Musso

Biol Blood Marrow Transplant· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One year of clinical experience in postdilution hemofiltration with online reinfusion of regenerated ultrafiltrate.
Carlo Meloni, Paolo M Ghezzi, Silvia Cipriani, Sandro Petroni, Giovanni Del Poeta, Bernardo Rossini

Blood Purif· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure.
Carlo Meloni, Paola Tatangelo, Silvia Cipriani, Valeria Rossi, Concetta Suraci, Bernardo Rossini

J Ren Nutr· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis